Republic Of Korea to India: Potassium Import Trade Route

The Republic Of Korea to India Potassium corridor is one of India's established pharmaceutical import routes from Republic Of Korea, with 5 shipments documented worth a combined $288.4K USD. The route is dominated by CKD BIO CORPORATION, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Republic Of Korea's potassium export sector.

Across 1 active Republic Of Korea suppliers, the average shipment value stands at $57.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with potassium's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 22.5%, placing it at rank #2 among India's top potassium import origins globally.

On the Indian buyer side, key Indian importers include MEDICEF PHARMA, UNI MEDICOLABS. MEDICEF PHARMA is the single largest Indian importer with 1 shipments valued at $190.6K USD.

India's potassium imports from Republic Of Korea are driven primarily by a handful of large-scale Republic Of Korea manufacturers. CKD BIO CORPORATION with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Republic Of Korea supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CKD BIO CORPORATION — together account for 100% of total trade value on this route. The average shipment value of $57.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as potassium clavulanate with microcrystalline cellulose (1:1) i.p. e.p. (for human products consumption only)potassium clavulanate with microcrystalline cellulose (1:1) and potassium clavulanate with silicon dioxide (1:1) i.p., e.p. (for human products consumption only)potassium clavulanate with silicon dioxide (1:1) i.p., e.p., suggesting that Indian buyers tend to consolidate orders across related product lines from the same Republic Of Korea supplier.

On the buying side, MEDICEF PHARMA is the largest importer with 1 shipments worth $190.6K USD — representing 66% of all potassium imports from Republic Of Korea on this route.